Plynt is a plant health diagnosis app for iOS that uses photo analysis to identify diseases and provide staged treatment plans.
The App DNA
What makes this app unique?
The app removes the cognitive cost of researching plant symptoms by providing a differential diagnosis with confidence scores, allowing users to act on treatment plans with higher certainty.
For Home gardeners and plant owners seeking specific, actionable advice for plant health issues.
What does it look like?
Key features
Displays a confidence percentage for the primary diagnosis alongside ruled-out look-alike conditions.
Provides actionable steps categorized into immediate fixes, ongoing care, and prevention tactics.
Saves diagnosis history and provides care reminders for specific plants.
How much does it cost?
The freemium model uses a single-use free trial to demonstrate diagnostic capability before gating unlimited access and advanced features behind a subscription.
Velocity
Maintenance developmentopaqueShow more...
The app is currently in its early lifecycle, with only one release shipped in the last 21 days. Given the current cadence of a single version, the development trajectory is classified as maintenance until further updates demonstrate a consistent release pattern. There is no evidence of live operations or recurring content updates at this stage. Future development will clarify whether this represents a stable release or a slower, long-term maintenance cycle.
Who built it?
User Sentiment
What do users think recently?
How are ratings & reviews evolving?
Not enough recent reviews to extract reliable themes yet.
Read the full review analysisCompetition
Competitive landscape for Plynt: Plant Disease Diagnosis
How's the Lifestyle market?
Plynt enters the lifestyle category as a new entrant, having launched its first version in July 2026. The current strategy relies on a high-intent conversion funnel where the single free diagnosis must demonstrate enough value to justify the $29.99 annual subscription.
Read the market outlookThe rivals identified
Unlock the deeper market read.
Access the full report for freeThe Analyst's Read
Key takeaways for Plynt: Plant Disease Diagnosis
Where is it heading?
The plant health diagnosis market is consolidating around apps that offer long-term care tracking and high-confidence identification. Plynt's focus on differential diagnosis positions it well for high-intent users, but the current lack of update cadence leaves it vulnerable to competitors who iterate on their diagnostic models more frequently.
- The app remains in its initial release phase, with no major feature updates since the July 2026 launch.
The SWOT
- Differential diagnosis mechanism provides confidence scores for primary conditions
- Expanding region-aware database for niche outdoor garden plants
Next best moves
Expand free trial to three diagnoses because the current single-use limit prevents trust-building → increase conversion rate
The counter-intuitive read
The single-use free trial is a strategic error…
Read the full takeSince the last report: Plynt pivoted its development roadmap from iPad UI expansion to a trial-funnel experiment, prioritizing a higher free-scan limit to address conversion barriers. The app's competitive narrative now centers on the challenge of justifying its $29.99 annual subscription through high-intent diagnostic trust.
Bottom line
Plynt's differential diagnosis mechanism provides a clear value-add for users who need to trust a treatment plan before acting, but the single-use free trial creates a high conversion barrier that may suppress early user growth.
Unlock 1 critical friction, 1 market threat and the analyst’s take.
Access the full report for freeSources
- [1] App Store, source
Report last updated